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Abstract
Background: Previous research has suggested that music therapy may facilitate skills in areas typically affected by
autism spectrum disorders such as social interaction and communication. However, generalisability of previous
findings has been restricted, as studies were limited in either methodological accuracy or the clinical relevance of
their approach. The aim of this study is to determine effects of improvisational music therapy on social
communication skills of children with autism spectrum disorders. An additional aim of the study is to examine if
variation in dose of treatment (i.e., number of music therapy sessions per week) affects outcome of therapy, and to
determine cost-effectiveness.
Methods/Design: Children aged between 4;0 and 6;11 years who are diagnosed with autism spectrum disorder
will be randomly assigned to one of three conditions. Parents of all participants will receive three sessions of
parent counselling (at 0, 2, and 5 months). In addition, children randomised to the two intervention groups will be
offered individual, improvisational music therapy over a period of five months, either one session (low-intensity) or
three sessions (high-intensity) per week. Generalised effects of music therapy will be measured using standardised
scales completed by blinded assessors (Autism Diagnostic Observation Schedule, ADOS) and parents (Social
Responsiveness Scale, SRS) before and 2, 5, and 12 months after randomisation. Cost effectiveness will be
calculated as man years. A group sequential design with first interim look at N = 235 will ensure both power and
efficiency.
Discussion: Responding to the need for more rigorously designed trials examining the effectiveness of music
therapy in autism spectrum disorders, this pragmatic trial sets out to generate findings that will be well
generalisable to clinical practice. Addressing the issue of dose variation, this study’s results will also provide
information on the relevance of session frequency for therapy outcome.
Trial Registration: Current Controlled Trials ISRCTN78923965.
Background
Impairments or delayed development in skills concern-
ing social interaction and communication are at the
core of autism spectrum disorders (ASD) [1]. The
attempts to help children with ASD develop meaningful
language and social communication skills cover a wide
range of different approaches. Yet, for most of the var-
ious intervention methods available and reported within
ASD that are designed to improve communication and
social interaction, only insufficient evidence of effective-
ness exists [2]. Some favourable results can be found for
approaches such as early behavioural interventions [3,4]
and augmentative communication [5]. However, if meth-
odologically rigorous standards are applied, statistically
significant improvements in communication and speech
could hitherto only be ascertained in a parent-mediated
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mediated behavioural interventions [2], and music ther-
apy [2,7]. Similarly, in a review of “novel and emerging
treatments” for ASD [8] including several nutritional
supplements, diets, medications, and nonbiological treat-
ments, it was found that the only treatment options that
reached the highest ranking in an evidence-based grad-
ing system were melatonin, acetylcholinesterase inhibi-
tors, naltrexone, and music therapy. Considering that
pharmacological treatments typically target symptoms
such as hyperactivity, agitation, or sleep disorders rather
than core symptoms of ASD, and may have adverse
effects [2,8], music therapy can be viewed as a promis-
ing, but not yet sufficiently evidenced treatment for
improving social interaction and communication skills
within ASD. Due to various methodological quality lim-
itations of previous studies [2], further high quality ran-
domised controlled trials (RCTs) on common
interventions for ASD have been found to be urgently
needed.
Music therapy has a long tradition within ASD [9,10],
and there are many clinical reports, case studies, and
single group studies (e.g. [11-13]; for an overview, see
[14]) suggesting that music therapy may enhance skills
of social communication such as initiating and respond-
ing to communicative acts. In recent years, increased
efforts have been made to conduct more rigorous stu-
dies in this area. A Cochrane review combining the find-
ings of three small controlled studies of music therapy
in children with ASD [7] concluded that this type of
intervention may have positive effects on the communi-
cative skills of children with ASD, but also noted limited
applicability of the studies’ results to clinical practice
due to very short duration of treatment conditions and
low flexibility in music therapy techniques applied.
Following this review, some RCTs were conducted
that strived for improved clinical relevance by applying
treatment durations of several months as well as impro-
visational, flexible, child-centred methods of music ther-
apy provided by trained therapists [15-17].
Improvisational music therapy for children with ASD
may generally be described as a child-centred approach
making use of the potential for social engagement and
expression of emotions occurring through improvisa-
tional music making. Instead of practising targeted skills
in an abstract manner, improvisational music therapy has
been noted for its potential to provide a meaningful fra-
mework that, similar to early mother-infant interaction,
encompasses relevant features of social communication
such as being embedded in a shared history of interac-
tion, having a common focus of attention, turn-taking,
and musical and emotional attunement [15-18]. In the
first of these newer RCTs on child-centred music therapy
methods [15], it was suggested that improvisational
music therapy may facilitate skills fundamental to social
interaction in children with autism and proves to be
effective in improving lower levels of initiating joint
attention and responding to joint attention bids. Despite
this trial’s significant results, some methodological con-
straints such as its small sample size (N = 10) and large
number of outcome measures limited the generalisability
of its findings. Recent RCTs with slightly larger sample
sizes of N = 23 (unpublished report, Thompson, McFer-
ran, and Wigram, 2011) and N = 24 [16], respectively,
also investigated effects of improvisational, child-centred
music therapy approaches on social communication skills
of young children with ASD, but were still seriously lim-
ited in sample size and test power. A large pragmatic
RCT is needed to decide if improvisational music therapy
improves core symptoms of ASD in a generalised setting.
Objectives
The objectives of this study are as follows:
1.) To determine whether music therapy is superior to
standard care in improving social communicative skills
in children with ASD as assessed by independent clini-
cians at the end of the treatment period.
2.) To determine whether music therapy is superior to
standard care in improving social responsiveness in chil-
dren with ASD as assessed by parents/guardians at the
end of the treatment period.
3.) To determine whether the response varies with
variation of treatment intensity.
4.) To determine how the development of social com-
municative skills proceeds until follow-up twelve
months after the start of treatment.
It is predicted that children’s social communicative
ability will increase over time, that social communicative
skills may be better in music therapy conditions than in
the standard care condition, and that more frequent
music therapy may intensify the improvement in the
skills assessed. Assessing participants’ social communica-
tive skills seven months after ending of treatment (12
months after randomisation) will yield important infor-
mation on whether any effects in the skills investigated
will be sustained.
Methods/Design
Participants
The study will include children referred from participat-
ing institutions (hospital departments, development cen-
tres, parents’ support groups) who comply with the
following criteria:
Inclusion criteria
(a) Aged 4;0 to 6;11: At their respective time of rando-
misation, the participants’ age ranges between 4;0 and
6;11. Given the nature of basic social communication
skills that are targeted in this study as occurring early in
Geretsegger et al. BMC Pediatrics 2012, 12:2
http://www.biomedcentral.com/1471-2431/12/2
Page 2 of 9development, inclusion of young children is considered
necessary; as it will be desirable for children to be able
to attend therapy sessions without their parents, the
lower age boundary was chosen based on the experience
that children will usually be able to attend therapy in a
one-to-one setting at that age; a further reason for set-
ting the lower boundary at 4 years is that one of the
scales measuring outcome (SRS, see below) is standar-
dised for children from age 4. The upper age boundary
was chosen in order to limit the sample to a group shar-
ing similar everyday life conditions in preschool settings
and/or around the time of transfer to school.
(b) Diagnosis of autism spectrum disorder: Participants
must have a diagnosis of an autism spectrum disorder
as assessed by a child psychiatrist or clinical psycholo-
gist according to ICD-10 criteria before their respective
baseline assessment. Participants’ diagnosis of ASD
needs to be reconfirmed in the baseline assessment with
children fulfilling diagnostic criteria for ASD on the
Autism Diagnostic Observation Schedule (ADOS) [19]
and on two of three domains of the Autism Diagnostic
Interview-Revised (ADI-R) [20].
Exclusion criteria
(a) Serious sensory disorder: Children participating in the
study must not be affected by serious sensory disorders
such as blindness or deafness as this would alter the
aim, course, and implementation of therapy.
(b) Previous experience of music therapy: Children hav-
ing had music therapy sessions prior to study enrolment
will not be included as this would be likely to have a
strong influence on the course of therapy.
Non-verbal children as well as children with language
skills may be included. Parents/guardians must give
informed consent for their children to be involved in
the study. Participants must be able to attend up to
three weekly music therapy sessions. In cases where
transportation to and from locations where the therapy
sessions take place might be difficult to provide by par-
ents/guardians, travelling allowances may be made avail-
able to avoid bias or drop-out due to any family’s
financial restrictions.
Baseline assessment
To support the diagnosis of autism, and to establish a
baseline of the respective outcome measure, the Autism
Diagnostic Observation Schedule (ADOS) [19] will be
administered to potential participants. Additionally, the
Autism Diagnostic Interview-Revised (ADI-R) [20] will
be administered to parents/guardians to acquire data
not only on the behaviour displayed during baseline
assessment, but also on the history of development of
each child, and to avoid loss of specificity [21,22]. The
children’s level of cognitive ability will be assessed using
the Kaufman Assessment Battery for Children (K-ABC)
[23]. In cases where the application of the K-ABC is not
possible due to the respective child’s limitations in com-
plying with the requirements of the testing situation,
children’s level of cognitive functioning will be estimated
by the assessor to fall into one of three categories (no
mental retardation vs. mild mental retardation vs. mod-
erate to profound mental retardation according to ICD-
10 criteria) using clinical judgment. To establish the
baseline of the secondary outcome measure, parents/
guardians will be asked to complete the Social Respon-
siveness Scale (SRS) [24]. In addition, standard demo-
graphic parameters (gender, age, first language, family
size, parents’ educational background), comorbidities,
and information on concomitant treatment will be
recorded.
Interventions
Participants will be randomly assigned to one of the fol-
lowing three conditions:
(1) High-intensity music therapy: Improvisational
music therapy sessions in an individual setting thrice
weekly for five months (i.e., a total of up to 60 sessions,
depending on possible omission of single sessions due
to sickness or holidays), and three sessions of parent
counselling as a “standard care condition” (one session
at baseline, one after two months, and a third one after
five months).
(2) Low-intensity music therapy: Improvisational music
therapy sessions in an individual setting once a week for
five months (i.e., a total of up to 20 sessions), and three
sessions of parent counselling (at baseline, two months,
and five months).
(3) Standard care: Three sessions of parent counsel-
ling (at baseline, after two months, and after five
months).
Concomitant treatment
Any concomitant treatment or therapeutic interventions
that participating children might receive outside the trial
will be recorded during assessment sessions before ran-
domisation and after 2, 5, and 12 months, specifying the
kind and amount or frequency of intervention.
We consider a treatment duration of five months to
be sufficient for detectable developments in children’s
social communication skills. Some of the earlier RCTs
on music therapy in autism [15-17] were able to identify
effects with shorter or similar duration; see also a meta-
analysis of the dose-effect relationship in music therapy
[25]. Additionally, we believe this time frame not to be
overly long for being able to sustain parents’/guardians’
motivation to participate in the study.
Description of music therapy
The duration of music therapy sessions will be 30 min-
utes. Therapists conducting the music therapy sessions
will be trained music therapists (master’s level or
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children with ASD.
The music therapy approach applied in this study is
based on the ideas and principles of improvisational
music therapy [26,27], findings from previous music
therapy research [13,15-17,28], and developmental psy-
chology [29]. The music played or sung by the therapist
is generally attuned to the child’s (musical or other)
behaviour and expression and includes various improvi-
sational techniques to engage the child and establish
contact with the child. To this end, “musical” features of
the child’s expression (pulse, rhythmic, dynamic or
melodic patterns, timbre etc.) may be mirrored, rein-
forced, or complemented, thus allowing for moments of
synchronisation between child and therapist and giving
the child’s expressions a pragmatic meaning within the
context. To allow elicitation of specific social communi-
cative behaviours, the therapist may also gently provoke
the child e.g. by violating expectations or jointly devel-
oped patterns. While engaging in joint musical activities
within a shared history of interaction, the child is
offered opportunities to develop and enhance skills such
as affect sharing, joint attention, imitation, reciprocity,
and turn-taking, all of which are associated with later
development in language and social competency [30,31].
Description of parent counselling
Parent counselling sessions will be approximately 60
minutes and will be conducted by a music therapist
and/or clinical psychologist experienced in the field of
ASD. Counselling sessions will comprise supporting
conversations with a focus on current concerns, pro-
blems, and difficulties arising from the child’sd i a g n o s i s ,
behaviour, and development over time as well as provid-
ing information about ASD, child development, and
social communication relevant to the families’ everyday
life situations.
Treatment guide for music therapy and parent counselling
Music therapy and parent counselling sessions will both
be provided in accordance with a treatment guide
devised for this study in order to specify the treatment
procedures and to allow for training of staff and replica-
tion of treatment. Within this guide, the setting, general
goals, and basic principles of the intervention as well as
exemplifications will be outlined. The guidelines are to
be administered flexibly according to the requirements
of the respective situation and needs of the client or
parent within the therapy process or counselling session
and can only be applied in combination with and relying
on the clinical expertise of the therapist or counsellor.
W h i l et h et r e a t m e n tg u i d ew i l lh e l pt oe n s u r et h e
trial’s validity and replicability, it is also important to
retain flexibility and openness to emerging procedures
within music therapy in clinical practice [32]. Keeping
enough “space” for flexible adaptation within the
treatment guide according to the child’ss p o n t a n e o u s
social behaviours will also ensure that the intervention
will be shaped in a way that is tailored to the individual
strengths and needs of each child, thus addressing the
great variability of developmental profiles present in
children on the autism spectrum. The treatment guide
will be described in a separate paper.
Assessment of treatment fidelity
To determine if the treatment is conducted as intended,
fidelity check measures will be applied as follows: after
every session, the therapist/counsellor will document
significant events, notable child/parent behaviours, and
interventions applied. In addition to these self-reports,
all therapy and parent counselling sessions will be video-
taped to allow for assessment by independent raters
[33]. As in a previous RCT in music therapy [34], adher-
ence to the method and competence in its application
will also be monitored and sustained through clinical
supervision of music therapists/counsellors, utilising the
therapists’ clinical notes and video-recordings of sessions
where necessary.
Study design
The study will be a pragmatic international multicentre
single-blind (assessor-blinded) randomised controlled
trial with three parallel arms. After inclusion in the
study and baseline assessment, participants will be
assigned to one of the music therapy conditions or the
standard care condition on an individual basis according
to a computer generated randomisation list. The alloca-
tion ratio of intended numbers of participants in the
comparison groups will be 1:1:2 so that the number of
children receiving music therapy will be similar to the
number of participants in the standard care condition.
To this end, randomisation will be made in blocks with
random sequences of block sizes of 4 or 8 respectively
(a separate list for each site) to avoid possible guessing
of some allocations. Before random assignment is per-
formed, it has to be confirmed by the investigator
recruiting participants that the eligibility criteria have
been met and participants are formally enrolled. Once
recruitment and data collection at baseline are complete
and informed consent to participate in the study by the
parents/guardians has been obtained, the respective ran-
domisation code will be revealed to the investigator by
an administrative person at the central randomisation
office who will have no contact to participants. An over-
view of the study design is shown in Figure 1.
Power calculation and sample size
Estimate of effect size
A Cochrane review on music therapy for ASD found
effect sizes (standardised mean differences) of d = 0.50
and 0.36 for gestural and verbal communicative skills,
Geretsegger et al. BMC Pediatrics 2012, 12:2
http://www.biomedcentral.com/1471-2431/12/2
Page 4 of 9respectively [7]. However, these figures were derived
from small studies with low precision and using unpub-
lished scales [7]. A more precise estimate using the
ADOS scale may be derived from the PACT trial [6]
where an effect of d = 0.24 was found. That study was
more similar in design to the present study but used a
different behavioural intervention. In summary, an effect
size in the small (d = 0.20) to medium (d = 0.50) range
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High-intensity music therapy:
improvisational music therapy,  
three sessions per week (up to 60 
sessions),
parent counselling (3 sessions) 
continued for 5 months 
randomisation – continued until stopping boundary is reached 
2 months (intermediate) & 5 months (end of intervention) after randomisation:  
assessment using ADOS (blind assessors) & SRS (parents); obtaining information on concomitant treatment 
all children at participating institutions 
- aged 4;0 – 6;11 
- diagnosed with autism spectrum disorder 
- no serious sensory disorder 
- no previous experience of music therapy 
first contact with investigator: 
agreement to participate in the study? 
(written informed consent)
reported, but 
not followed-up
pretest/baseline assessment on ASD 
(ADOS, ADI-R) & cognitive ability 
(K-ABC) by blind assessors; parent report 
(SRS); obtaining information on 
concomitant treatment 
Low-intensity music therapy:
improvisational music therapy,  
one session per week (up to 20 
sessions),
parent counselling (3 sessions) 
continued for 5 months 
Standard care:
parent counselling (3 sessions), 
no music therapy 
continued for 5 months 
assessment of treatment fidelity: therapist/counsellor self-rating, videotaping of all sessions, independent rating 
of randomly selected sessions, supervision of therapists/counsellors 
12 months after randomisation (follow-up):  
assessment using ADOS (blind assessors) & SRS (parents); obtaining information on concomitant treatment 
yes
no 
Figure 1 Flow chart of the study design. Abbreviations: ASD - autism spectrum disorders; ADOS - Autism Diagnostic Observation Schedule;
ADI-R - Autism Diagnostic Interview-Revised; K-ABC - Kaufman Assessment Battery for Children; SRS - Social Responsiveness Scale.
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difference on the ADOS scale that typically has SD = 5
[6]. An effect size in this range would be clinically
meaningful as the ADOS scale measures the core symp-
toms of ASD which are difficult to influence with any
treatment.
Parameters for sample size calculation
The two music therapy arms (high- and low-intensity)
will be taken together for the primary analysis to answer
the question if music therapy in general is superior to
standard care. Half of all participants will be assigned to
music therapy. In light of the uncertainty around the
true effect size and the difficulty of recruiting large sam-
ples, a group sequential design (GSD, [36]) will ulti-
mately ensure 80% power (two-sided alpha 0.05) even
for a small effect, while avoiding excessively large sam-
ple size if there is in fact a medium effect. We used the
common Lan-DeMets alpha spending function and a
Pocock boundary to make early stopping likely. Calcula-
tions and simulations were made for up to four equally
spaced looks, using East 5.4 software by Cytel Inc., 2010.
Results
Table 1 shows that if there is a medium effect of music
therapy, power at the first interim look (usable N = 235)
will be 93%. Power will also be acceptable (76%) if the
effect is slightly smaller than medium. If there is only a
small effect size, power can still be retained by recruit-
ing more participants. An independent data monitoring
committee will perform the interim look. We will aim
to randomise N = 300 participants (150 to standard care
and 75 to each type of music therapy) to account for
possible drop-outs and clustering within sites [37]. How-
ever, the actual interim look may be taken at a different
sample size, depending on recruitment progress and
funding.
Outcomes
The study will use assessments by blinded clinicians as
well as reports by parents/guardians. Outcome variables
will be assessed at several time points: after the baseline
assessment (taking place before each individual’sr a n d o -
misation), the outcome measures will be reapplied after
an interval of two months (intermediate), once again
after an interval of five months (end of intervention),
and finally at follow-up twelve months after randomisa-
tion. Thus, requirements such as close analysis of the
mechanism of action (i.e. how long an intervention is
required to begin to have an effect) and investigation on
maintenance of any observed changes over a longer per-
iod of time [2] can be met.
Primary outcome
To allow for potential comparison with studies investi-
gating similar interventions as well as for potential
inclusion in later reviews, a validated scale widely used
in research and academic practice will be used for
assessing social communication skills: The Autism
Diagnostic Observation Schedule (ADOS) is a semi-
structured, standardised observation instrument
designed to assess communication, social interaction,
and play or imaginative use of materials using 28 to 31
specific behavioural criteria in one of four modules
chosen individually depending on the respective child’s
expressive language level and chronological age [19].
Inter-rater reliability, test-retest reliability, and internal
validity have been demonstrated for the ADOS [19].
The ADOS is viewed especially suitable for this study
considering that, although standardised, its assessment
is based on play-based interactions between assessor
and child, thus similar in its setting to the music ther-
apy situation. This study’s primary outcome will be the
ADOS social communication algorithm score which
has been used as an outcome measure in previous
RCTs investigating effects of interventions for autism
[6,38,39]. In order to improve sensitivity to change, the
scoring procedure will be modified as in an earlier
RCT on treatment effects [6], i.e. the module applied
to each child will be the same across assessment points
(instead of adjusting the module to potentially devel-
oped expressive language skills) to avoid discontinuity
of scores, and the full range of scores will be retained
(instead of recoding 3’st o2 ’sa si nt h es t a n d a r dd i a g -
nostic algorithm) [40].
To avoid bias in observation and assessment, assessors
administering the instrument will be blinded to group
allocation of the children to be assessed. This will be
secured for example by having the assessments take
place in another location than music therapy sessions.
Success of blinding will be verified by asking assessors
Table 1 Sample size and power under different scenarios
Raw difference on the ADOS scale (SD =
5)
Standardised effect size (Cohen’s
d)
Power at first interim
look
1
Test power over all 4 interim
looks
2
2.5 0.5 (medium effect) 93% 100%
2 0.4 76% 100%
1.5 0.3 47% 99%
1 0.2 (small effect) 20% 80%
Note. Based on 10000 simulations for each scenario.
1Usable N = 235 (300 randomised).
2Maximum usable N = 939.
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child’s allocation.
Secondary outcomes
In order to supplement the assessment, parents/guar-
dians will be asked to complete the Social Responsive-
ness Scale (SRS) [24] at baseline, and two, five, and
twelve months after randomisation. The 65-item rating
scale measures the severity of autism spectrum symp-
toms occurring in natural social settings, assessing social
awareness, social information processing, capacity for
reciprocal social communication, social anxiety/avoid-
ance, and autistic preoccupations and traits. Defined as
suitable for assessing treatment response [41], these five
subscales seem appropriate as secondary outcome mea-
sures. The scale features high inter-rater and test-retest
reliability as well as internal validity rates and may be
completed in 15 to 20 minutes [42-44], thus easily
applicable during appointments.
Cost-effectiveness of music therapy will be compared
to standard care. Cost will be measured as real resources
used in treatment, in terms of personnel hours of work.
Effectiveness is measured by ADOS, and cost-effective-
ness ratios and incremental cost-effectiveness ratios for
the different alternatives can be calculated. Gains for the
general health care sector and society will be more long
term, and can hardly be included in this project. How-
ever, some consideration will be made as to possible
effects on school attainment. Costs can be made com-
parable across countries using purchasing power parity
measures.
Statistical analyses
The primary analysis will be undertaken on an inten-
tion-to-treat basis, and two-sided tests will be applied at
a 5% alpha level. Following assessment of normality,
treatment effects will be analysed using a generalized
estimating equations (GEE) approach that allows for
analysis of longitudinal data while accounting for the
correlation among the repeated observations for each
subject [45]. GEE analyses will also be used to examine
dose-effect relationships and to explore possible con-
founding effects of site or relevant subgroups such as
age or ASD subtype.
Ethical issues
The study protocol was approved by the Faculty of
Humanities’ Human Research Ethics Board (HREB) at
Aalborg University, Denmark. Freely given, written
informed consent will be obtained from participant’s
parents/guardians prior to study enrolment in accor-
dance with regulatory requirements. Random allocation
of participants to study groups is considered reasonable
as no adverse effects are expected in any of the
conditions. Inconveniences caused by the necessity to
attend three weekly sessions of music therapy for the
families assigned to this study group are considered tol-
erable in view of the anticipated benefit for the child
receiving therapy.
Discussion
High clinical applicability of this RCT’sf i n d i n g si st ob e
achieved through therapy conditions that are close to
clinical practice in terms of broad eligibility criteria (ver-
bal and non-verbal children, all types of ASD), treat-
ment duration (several months), and therapy techniques
(improvisational music therapy conducted by experi-
enced therapists in a typical setting).
The study’s limitations are also its strengths: The
absence of outcomes proximal to music therapy [15,17];
the heterogeneity of standard care as a control condi-
tion; and the heterogeneity of the population [46] may
be seen as limitations, but are features that will improve
feasibility and that are in line with pragmatic trials of
effectiveness whose focus is to help users choose
between options [47].
Conclusions that will emerge from this study are
expected to contribute to the evidence base of treatment
options for children with ASD. The results of the trial
will provide evidence on the effectiveness of music ther-
apy as a treatment for ASD and will also provide infor-
mation on the relevance of session frequency for
therapy outcome. Furthermore, findings gained through
the application of a treatment guide within this study
may help to further specify music therapy treatment
guidelines for this population and to enrich future train-
ing and education of music therapists and other health
care professionals working in the field of ASD.
Findings of this study will also be relevant for other
fields where music therapy is applied, such as adult
mental health [10,25], and for basic research into the
musical qualities of early mother-infant communication
providing a rationale for music therapy [18,29]. Music
therapy in general is an intervention that focuses on
developing social and emotional abilities, and ASD is a
case in point because impairments in these abilities are
central for ASD.
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